Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date CONTINUOUS MANUFACTURING OF BIOLOGICS: A JOURNEY FROM CONCEPT TO REALITY Himanshu Gadgil at Enzene Biosciences Ltd and Ganesh Kumar, at Sartorius Full Title: Opportunities and Challenges in Developing a Fully-Connected Continuous Manufacturing Process for Biologics Insights through case studies... 2 years ago | 113 mins Effect of Cell Culture Process Change from Fed-batch to Continuous on... Ru Zang, Associate Director at Mersana Therapeutics and John Bonham Carter,Project Line Lead at Repligen EFFECT OF CELL CULTURE PROCESS CHANGE FROM FED-BATCH TO CONTINUOUS ON PRODUCTIVITY AND PRODUCT QUALITY Integrated continuous bioprocessing has attrac... 4 years ago | 76 mins Fully continuous biosimilar manufacturing framework: A case study Samir Varma, Head of Manufacturing, Enzene Biosciences and Lotta Molander, Global Product Manager, GE Healthcare Biologics manufacturing has traditionally been in fed batch mode for the last 2 decades. During the early stages of biologics manufacturing, lower cel... 5 years ago | 68 mins Cost Considerations for the Application of Continuous Processing Narasimha Rao Nedunuri, CEO of CLONZ Biotech and Tania Pereira Chilima, Product Manager at Univercells Cost contribution of continuous manufacturing both in operational and capital expenditure in Monoclonal antibody production. Evaluating cost of produc... 3 years ago | 63 mins Understanding the Propensity of Sequence Variants During Cell Line & Culture... Dr. Lisa Marzilli, Associate Research Fellow and group leader Mass Spectrometry at Pfizer, USA Sequence variants (SVs) are protein isoforms that contain one or more unintended amino acid substitutions. They can arise at a single amino acid site ... 4 years ago | 40 mins New Tools to Assess the Risk of Microbial Impurities in the Pharmaceutical... Presented by Friedrich von Wintzingerode Global QC at Roche Followed by Mathilde Arnault, Research Scientist at Merck KGaA, Full Title: New Tools to Assess the Risk of Microbial Impurities in the Pharmaceutical Manufacturing Process Large scale Production of Biologics is s... 4 years ago | 62 mins Development and Implementation of Intensified Bioprocessing for Biologics... Hang Zhou at WuXi Biologics and Huan Xiong at Repligen Full Title: Development and Implementation of Intensified Bioprocessing for Biologics Manufacturing There are increasing needs for flexibility and sp... 2 years ago | 93 mins How to Utilize Design of Experiments (DoE) Principles for the Development of... Jeremy Springall PhD, Scientist II, Analytical Sciences, R&D Biopharmaceutical Development, AstraZeneca Full Title: How to Utilize Design of Experiments (DoE) Principles for the Development of High Throughput, Robust Methods for the Assessment of Product... 4 years ago | 44 mins Characterization of Biotherapeutics Diane McCarthy, PhD, Senior Scientific Liaison, US Pharmacopeia and Kai Scheffler Product Manager at Thermo Fisher Scientific By Diane McCarthy, PhD, Senior Scientific Liaison, Global Biologics, US Pharmacopeia Biotherapeutic products are typically characterized by multiple ... 3 years ago | 76 mins Cost Considerations for the Application of Continuous Processing Narasimha Rao Nedunuri, CEO of CLONZ Biotech and Tania Pereira Chilima, Product Manager at Univercells Cost contribution of continuous manufacturing both in operational and capital expenditure in Monoclonal antibody production. Evaluating cost of produc... 3 years ago | 62 mins
